Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-22T16:24:30.199Z Has data issue: false hasContentIssue false

Insights into neutralization of animal viruses gained from study of influenza virus

Published online by Cambridge University Press:  15 May 2009

M. C. Outlaw
Affiliation:
Department of Biological Sciences, University of Warwick, Coventry CV4 7AL
N. J. Dimmock
Affiliation:
Department of Biological Sciences, University of Warwick, Coventry CV4 7AL
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

It has long been known that the binding of antibodies to viruses can result in a loss of infectivity, or neutralization, but little is understood of the mechanism or mechanisms of this process. This is probably because neutralization is a multifactorial phenomenon depending upon the nature of the virus itself, the particular antigenic site involved, the isotype of immunoglobulin and the ratio of virus to immunoglobulin (see below). Thus not only is it likely that neutralization of one virus will differ from another but that changing the circumstances of neutralization can change the mechanism itself. To give coherence to the topic we are concentrating this review on one virus, influenza type A which is itself well studied and reasonably well understood [1–3]. Reviews of the older literature can be found in references 4 to 7.

Type
Special Article
Copyright
Copyright © Cambridge University Press 1991

References

REFERENCES

1.Dimmock, NJ. Mechanisms of neutralization of animal viruses. J Gen Virol 1984; 65: 1015–22.CrossRefGoogle ScholarPubMed
2.Dimmock, NJ. Multiple mechanisms of neutralization of animal viruses. TIBS 1987; 12: 70–5.Google Scholar
3.Iorio, RM. Mechanisms of neutralization of animal viruses: monoclonal antibodies provide a new perspective. Microbiol Path 1988; 5: 17.CrossRefGoogle ScholarPubMed
4.Svehag, S-E. Formation and dissociation of virus-antibody complexes with special reference to the neutralization process. Prog Med Virol 1968; 10: 163.Google Scholar
5.Mandel, B. Neutralization of animal viruses. In: Advances in virus research, volume 23. New York: Academic Press, 1978: 205.Google Scholar
6.Mandel, B. Interaction of viruses with neutralizing antibodies. In: Fraenkel-Conrat, H and Wagner, RR, eds. Virus–host interactions. Comprehensive virology, volume 15. New York: Plenum Press, 1979: 37.CrossRefGoogle Scholar
7.Mandel, B. Virus neutralization. In: van Regenmortel, MHV and Neurath, AR, eds. Immunochemistry of viruses. Amsterdam: Elsevier Science Publishers, 1985: 5370.Google Scholar
8.Taylor, HP, Armstrong, SJ, Dimmock, NJ. Quantitative relationships between an influenza virus and neutralizing antibody. Virol 1987; 159: 288–98.CrossRefGoogle ScholarPubMed
9.Lentz, TL. The recognition event between virus and host cell receptor: a target for antiviral agents. J Gen Virol 1990; 71: 751–66.CrossRefGoogle ScholarPubMed
10.Matlin, KS, Reggio, H, Helenius, A, Simons, K. Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 1981; 91: 601–13.Google Scholar
11.Marsh, M. The entry of enveloped viruses into cells by endocytosis. Biochem J 1984; 218: 110.Google Scholar
12.Patterson, S, Oxford, JS. Early interactions between animal viruses and the host cell: relevance to viral vaccines. Vaccine 1986; 4: 7990.Google Scholar
13.McClure, MO, Marsh, M, Weiss, RA. Human immunodeficiency virus infection of CD4- bearing cells occurs by a pH-independent mechanism. EMBO J 1988; 7: 513–18.Google Scholar
14.Russell, PH. Newcastle disease virus and two influenza viruses: differing effects of acid and temperature on the uptake of infectious virus into bovine and canine kidney cell lines. Arch Virol 1986; 88: 159–66.Google Scholar
15.Outlaw, MC, Dimmock, NJ. Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin. J Gen Virol 1990; 71: 6976.CrossRefGoogle ScholarPubMed
16.Outlaw, MC, Armstrong, SJ, Dimmock, NJ. Mechanisms of neutralization of influenza virus in traeheal epithelial and BHK cells vary according to IgG concentration. Virology 1990; 178: 478–85.Google Scholar
17.Icenogle, J, Shiwen, H, Duke, G, Gilbert, S, Rueckert, RR, Andereg, J. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. Virol 1983; 127: 412–25.CrossRefGoogle ScholarPubMed
18.Wiley, DC, Wilson, IA, Skehel, JJ. Structural identification of the antibody-binding sites of the Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (London) 1981; 289: 373–8.CrossRefGoogle Scholar
19.Taylor, HP, Dimmock, NJ. Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J Exp Med 1985; 161: 198209.CrossRefGoogle ScholarPubMed
20.Taylor, HP. The interaction of influenza virus with neutralizing antibody [PhD thesis]. University of Warwick, 1986.Google Scholar
21.Eisenlohr, LC, Gerhard, W, Hackett, CJ. Role of receptor-binding activity of the viral haemagglutinin molecule in the presentation of influenza virus antigens to helper T cells. J Virol 1987; 61: 1375–83.CrossRefGoogle ScholarPubMed
22.Jackson, RL, Segrest, JP, Kahane, I, Marchesi, VT. Studies on the major sialoglycoprotein of the human red cell membrane. Biochem 1973; 12: 3131–8.Google Scholar
23.Viitala, J, Jarnefelt, J. The red cell surface revisited. TIBS 1985; 10: 392–5.Google Scholar
24.Burton, RD. Is IgM-like dislocation a common feature of antibody function? Immunol Today 1986; 7: 165–7.CrossRefGoogle ScholarPubMed
25.Feinstein, A, Richardson, N, Taussig, MJ. Immunoglobulin flexibility in complement activation. Immunol Today 1986; 7: 169–74.Google Scholar
26.Pumphrey, R. Computer models of human immunoglobulins. Shape and segmental flexibility. Immunol Today 1986; 7: 174–8.Google Scholar
27.Possee, RD, Schild, GG, Dimmock, NJ. Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. J Gen Virol 1982; 58: 373–86.Google Scholar
28.Rigg, RJ, Carver, AS, Dimmock, NJ, IgG-neutralized influenza virus undergoes primary, but not secondary uncoating in vivo. J Gen Virol 1989; 70: 2097–109.CrossRefGoogle Scholar
29.Lafferty, KJ. The interaction between virus and antibody. I. Kinetic studies. Virol 1963; 21: 6175.CrossRefGoogle ScholarPubMed
30.Della-Porta, AJ, Westaway, EG. A multi-hit model for the neutralization of animal viruses. J Gen Virol 1977; 38: 119.Google Scholar
31.Peiris, JSM, Porterfield, JS, Roehrig, JT. Monoclonal antibodies against the flavivirus West Nile. J Gen Virol 1982; 58: 283–9.CrossRefGoogle ScholarPubMed
32.Chanas, AC, Gould, EA, Clegg, JCS, Varma, MGR. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity and independently inhibit haemagglutination or haemolysis. J Gen Virol 1982; 58: 3746.CrossRefGoogle ScholarPubMed
33.Armstrong, SJ, Outlaw, MC, Dimmock, NJ. Morphological studies of the neutralization of influenza virus by IgM. J Gen Virol 1990; 71: 2313–19.Google Scholar
34.Thomas, AAM, Brioen, P, Boeye, A. A monoclonal antibody that neutralizes poliovirus by crosslinking virions. J Virol 1985; 54: 713.Google Scholar
35.Thomas, AAM, Vrijsen, R, Boeye, A. Relationship between poliovirus neutralization and aggregation. J Virol 1986; 59: 479–85.CrossRefGoogle ScholarPubMed
36.Mandel, B. Neutralization of poliovirus: a hypothesis to explain the mechanism and one-hit character of the neutralization reaction. Virol 1976; 69: 500–10.CrossRefGoogle ScholarPubMed
37.Lee, PWK, Hayes, EC, Joklik, WK. Protein σ1 is the reovirus cell attachment protein. Virol 1981; 108: 156–63.CrossRefGoogle Scholar
38.Kukuhara, N, Yoshie, O, Kitaoka, S, Konno, T. Role of VP3 in human rotavirus internalization after target attachment via VP7. J Virol 1988; 62: 2209–18.CrossRefGoogle Scholar
39.Colonno, RJ, Callahan, PL, Leippe, DM, Rueckert, RR, Tomassini, JE. Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments. J Virol 1989; 63: 3642.CrossRefGoogle ScholarPubMed
40.Fox, G, Parry, NR, Barnett, PV, McGinn, B, Rowlands, DJ, Brown, F. The cell attachment site of foot-and-mouth disease virus includes the amino acid sequence RGD (arginine–glycine-aspartic acid). J Gen Virol 1989; 70: 625–37.CrossRefGoogle ScholarPubMed
41.McCahon, D, Crowther, JR, Belsham, GJ et al. , Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization: identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol 1989; 70: 639–45.CrossRefGoogle ScholarPubMed
42.Breschkin, AM, Ahern, J, White, DO. Antigenic determinants of influenza virus haemagglutinin. VIII. Topography of the antigenic regions of influenza virus determined by competitive radioimmunoassay with monoclonal antibodies. Virol 1981; 113: 130–40.CrossRefGoogle ScholarPubMed
43.McLain, L, Dimmock, NJ. Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutinin-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus. J Gen Virol 1989; 70: 2615–24.CrossRefGoogle Scholar
44.Gitelman, AK, Kaverin, NV, Kharitonenkov, IG, Rudneva, IA, Skylanskaya, EL, Zhadanov, VM. Dissociation of the haemagglutinin inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/70 (H1N1) virus variants with monoclonal antibodies. J Gen Virol 1988; 67: 2247–51.Google Scholar
45.Wharton, SA. The role of influenza virus haemagglutinin in membrane fusion. Microbiol Sci 1987; 4: 119–24.Google Scholar
46.Gollins, SW, Porterfield, JS. A new mechanism of the neutralization of enveloped viruses by antiviral antibody. Nature (London) 1986; 321: 244–6.CrossRefGoogle ScholarPubMed
47.Kida, H, Yoden, S, Kuwabara, M, Yanagawa, R. Interference with a conformational change in the haemagglutinin molecule of influenza virus by antibodies as a possible neutralization mechanism. Vaccine 1985; 3 (suppl): 219–22.Google Scholar
48.Yoden, S, Kida, H, Kuwabara, M, Yanagawa, R, Webster, RG. Spin-labelling of influenza virus haemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody. Virus Research 1986; 4: 251–61.CrossRefGoogle Scholar
49.Webster, RG, Brown, LE, Jackson, DC. Changes in the antigenicity of the haemagglutinin molecule of H3 influenza virus at acidic pH. Virol 1983; 126: 587–99.Google Scholar
50.Kjellen, L, von Zeipel, G. Influence of host cells on the infectivity and neutralizability of echovirus type 4 (Pesacek). Intervirol 1984; 22: 3240.Google Scholar
51.Kjellen, L. A hypothesis accounting for the effect of the host cell on neutralization-resistant virus. J Gen Virol 1985; 66: 2279–83.CrossRefGoogle ScholarPubMed
52.Kennedy-Stoskopf, S, Narayan, O. Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence. J Virol 1986; 59: 3744.CrossRefGoogle ScholarPubMed
53.Grady, LJ, Kinch, W. Two monoclonal antibodies directed against La Crosse virus show host-dependent neutralizing activity. J Gen Virol 1985; 6: 2773–6.CrossRefGoogle Scholar
54.Lubeck, M, Gerhard, W. Conformational changes at topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. Virol 1982; 118: 17.Google Scholar
55.Colman, PM, Laver, WG, Varghese, JN et al. , Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature (London) 1987; 326: 358–63.Google Scholar
56.Lamb, RA. The influenza virus RNA segments and their encoded proteins. In: Palese, P, Kingsbury, DW, eds. Genetics of influenza viruses. New York: Springer-Verlag, 1983.Google Scholar